Abstract
A series of novel derivatives of pyrimidine clubbed with thiazolidinone was synthesized in good yield and characterized by physiochemical and spectral means. All the synthesized derivatives were evaluated for their antimicrobial and anticancer activity. Antimicrobial properties of the title compounds were investigated against Gram positive (Bacillus subtilis and Staphylococcus aureus) and Gram negative bacterial (Escherichia coli) as well fungal strains (Candida albicans and Aspergillus niger). The anticancer evaluation of synthesized compounds against HeLa Cervical cancer cell Line indicated that (Z)-N-(5-(4-nitrobenzylidene)-4-oxo-2-phenylthiazolidin-3-yl)-6-methyl-4-(2-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide and (Z)-N-(5-(4-(diethylamino)benzylidene)-4-oxo-2-phenylthiazolidin-3-yl)-6-methyl-4-(2-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide (PT9, IC50 = 12.68μM and PT14, IC50 = 15.27μM) was the most active anticancer agent and was more potent than standard drug, Doxorubicin (IC50 =16.12μM). All newly synthesized compounds also exhibited promising results against microbial strains. Keywords: Pyrimidine, Thiazolidinone, Antimicrobial activity, HeLa Cancer cell line, Anti-cancer activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of medical pharmaceutical and allied sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
